Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2016 Volume 14 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2016 Volume 14 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain

  • Authors:
    • Hongmei Meng
    • Yuejia Song
    • Jiyuan Zhu
    • Qi Liu
    • Pengtian Lu
    • Na Ye
    • Zhen Zhang
    • Yuxin Pang
    • Jiping Qi
    • He Wu
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
    Copyright: © Meng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5535-5543
    |
    Published online on: November 7, 2016
       https://doi.org/10.3892/mmr.2016.5925
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Stroke is a life-threatening disease that results in significant disability in the human population. Despite the advances in current stroke therapies, a host of patients do not benefit from the conventional treatments. Thus, more effective therapies are required. It has been previously reported that leucine‑rich‑α2‑glycoprotein 1 (LRG1) is crucial during the formation of new blood vessels in retinal diseases. However, the function of LRG1 in the brain during the neovessel growth process following ischemic stroke has not been fully elucidated and the mechanism underlying its effect on angiogenesis remains unclear. The purpose of the current study was to demonstrate whether LRG1 may promote angiogenesis through the transforming growth factor (TGF)‑β1 signaling pathway in ischemic rat brain following middle cerebral artery occlusion (MCAO). In the present study, the spatial and temporal expression of LRG1, TGF‑β1, vascular endothelial growth factor (VEGF) and angiopoietin‑2 (Ang‑2) were detected in ischemic rat brain following MCAO using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), western blot analysis and immunohistochemistry. CD34 immunohistochemistry staining was used as an indicator of microvessel density (MVD). The RT‑qPCR and western blotting results revealed that the levels of LRG1 and TGF‑β1 mRNA and protein expression were significantly increased as early as 6 and 12 h after MCAO (P<0.05), respectively, peaked at 3 days and persisted at significantly higher level until 14 days, in comparison with the control group. Additionally, VEGF and Ang‑2 were also increased following MCAO. Furthermore, the immunohistochemistry results suggested that the MVD was increased following MCAO. In addition, the results also revealed that the percentage of LRG1‑positive cells was positively correlated with the percentage of TGF‑β1‑positive cells, and the percentage of LRG1‑positive and TGF‑β1‑positive cells had a positively correlation with the MVD. Taken together, the present study indicated that LRG1 may promote angiogenesis through upregulating the TGF‑β1 signaling pathway in ischemic rat brain following MCAO. This may provide a potential therapeutic target for the treatment of ischemic stroke.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Lundberg GP and Volgman AS: Burden of stroke in women. Trends Cardiovasc Med. 26:81–88. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Verma V, Samanthapudi K and Raviprakash R: Classic studies on the potential of stem cell neuroregeneration. J Hist Neurosci. 25:123–141. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Esposito E, Hayakawa K, Maki T, Arai K and Lo EH: Effects of postconditioning on neurogenesis and angiogenesis during the recovery phase after focal cerebral ischemia. Stroke. 46:2691–2694. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Zhang ZG and Chopp M: Promoting brain remodeling to aid in stroke recovery. Trends Mol Med. 21:543–548. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Moss A: The angiopoietin: Tie 2 interaction: A potential target for future therapies in human vascular disease. Cytokine Growth Factor Rev. 24:579–592. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Kwon HS, Kim YS, Park HH, Choi H, Lee KY, Lee YJ, Heo SH, Chang DI and Koh SH: Increased VEGF and decreased SDF-1α in patients with silent brain infarction are associated with better prognosis after first-ever acute lacunar stroke. J Stroke Cerebrovasc Dis. 24:704–710. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Shaikh H, Boudes E, Khoja Z, Shevell M and Wintermark P: Angiogenesis dysregulation in term asphyxiated newborns treated with hypothermia. PLoS One. 10:e01280282015. View Article : Google Scholar : PubMed/NCBI

8 

Haupt H and Baudner S: Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl). Hoppe Seylers Z Physiol Chem. 358:639–646. 1977.(In German). View Article : Google Scholar : PubMed/NCBI

9 

Takahashi N, Takahashi Y and Putnam FW: Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci USA. 82:1906–1910. 1985. View Article : Google Scholar : PubMed/NCBI

10 

Kobe B and Kajava AV: The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 11:725–732. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Kobe B and Deisenhofer J: Proteins with leucine-rich repeats. Curr Opin Struct Biol. 5:409–416. 1995. View Article : Google Scholar : PubMed/NCBI

12 

Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S, Ohkawara T, Nezu R, Nakajima S, Kobayashi T, et al: Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm Bowel Dis. 18:2169–2179. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Wong CC, Tse AP, Huang YP, Zhu YT, Chiu DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, et al: Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 60:1645–1658. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Zhang Y, Luo Q, Wang N, Hu F, Jin H, Ge T, Wang C and Qin W: LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells. Med Oncol. 32:1462015. View Article : Google Scholar : PubMed/NCBI

15 

Wu J, Yin H, Zhu J, Buckanovich RJ, Thorpe JD, Dai J, Urban N and Lubman DM: Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study. PLoS One. 10:e01211122015. View Article : Google Scholar : PubMed/NCBI

16 

Zhong D, Zhao S, He G, Li J, Lang Y, Ye W, Li Y, Jiang C and Li X: Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo. Tumour Biol. 36:4271–4278. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Liu YS, Luo XY, Li QR, Li H, Li C, Ni H, Li RX, Wang R, Hu HC, Pan YJ, et al: Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA and C4BP may refine prognosis of resected squamous cell lung cancer. J Mol Cell Biol. 4:344–347. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Wen SY, Zhang LN, Yang XM, Zhang YL, Ma L, Ge QL, Jiang SH, Zhu XL, Xu W, Ding WJ, et al: LRG1 is an independent prognostic factor for endometrial carcinoma. Tumour Biol. 35:7125–7133. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Kentsis A, Ahmed S, Kurek K, Brennan E, Bradwin G, Steen H and Bachur R: Detection and diagnostic value of urine leucine-rich α-2-glycoprotein in children with suspected acute appendicitis. Ann Emerg Med. 60:78–83.e1. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Shirai R, Hirano F, Ohkura N, Ikeda K and Inoue S: Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem Biophys Res Commun. 382:776–779. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Song W and Wang X: The role of TGFβ1 and LRG1 in cardiac remodeling and heart failure. Biophys Rev. 7:91–104. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, McDonald KM and Baugh JA: Proteomic analysis of coronary sinus serum reveals leucine-rich α2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure. Circ Heart Fail. 4:188–197. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Pek SL, Tavintharan S, Wang X, Lim SC, Woon K, Yeoh LY, Ng X, Liu J and Sum CF: Elevation of a novel angiogenic factor, leucine-rich-α2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes. J Clin Endocrinol Metab. 100:1586–1593. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Nakajima M, Miyajima M, Ogino I, Watanabe M, Miyata H, Karagiozov KL, Arai H, Hagiwara Y, Segawa T, Kobayashi K and Hashimoto Y: Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien). 153:1339–1346; discussion 1346. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Miyajima M, Nakajima M, Motoi Y, Moriya M, Sugano H, Ogino I, Nakamura E, Tada N, Kunichika M and Arai H: Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex. PLoS One. 8:e744532013. View Article : Google Scholar : PubMed/NCBI

26 

Wang X, Abraham S, McKenzie JA, Jeffs N, Swire M, Tripathi VB, Luhmann UF, Lange CA, Zhai Z, Arthur HM, et al: LRG1 promotes angiogenesis by modulating endothelial TGF-β signaling. Nature. 499:306–311. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Saito K, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Kawamoto S, Okubo K and Miyasaka M: Gene expression profiling of mucosal addressin cell adhesion molecule-1+ high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker. J Immunol. 168:1050–1059. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Zan L, Wu H, Jiang J, Zhao S, Song Y, Teng G, Li H, Jia Y, Zhou M, Zhang X, et al: Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: Correlations with angiogenesis and cerebral edema. Neurochem Int. 58:872–879. 2011. View Article : Google Scholar : PubMed/NCBI

29 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

30 

Yu Q, Zhao Z, Sun J, Guo W, Fu J, Burnstock G, He C and Xiang Z: Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract. Histochem Cell Biol. 133:177–188. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887. 1992. View Article : Google Scholar : PubMed/NCBI

32 

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, et al: Heart disease and stroke statistics-2015 update: A report from the American heart association. Circulation. 131:e29–e322. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Yoo SY and Kwon SM: Angiogenesis and its therapeutic opportunities. Mediators Inflamm. 2013:1271702013. View Article : Google Scholar : PubMed/NCBI

34 

Manoonkitiwongsa PS: Critical questions for preclinical trials on safety and efficacy of vascular endothelial growth factor-based therapeutic angiogenesis for ischemic stroke. CNS Neurol Disord Drug Targets. 10:215–234. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Nakajima M, Miyajima M, Ogino I, Watanabe M, Hagiwara Y, Segawa T, Kobayashi K and Arai H: Brain localization of leucine-rich α2-glycoprotein and its role. Acta Neurochir Suppl. 113:97–101. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Takemoto N, Serada S, Fujimoto M, Honda H, Ohkawara T, Takahashi T, Nomura S, Inohara H and Naka T: Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines. Oncotarget. 6:11009–11022. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Li Y, Zhang Y, Qiu F and Qiu Z: Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC. Electrophoresis. 32:1976–1983. 2011. View Article : Google Scholar : PubMed/NCBI

38 

Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S and Li E: Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA. 97:2626–2631. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Orlova VV, Liu Z, Goumans MJ and ten Dijke P: Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways. Histol Histopathol. 26:1219–1230. 2011.PubMed/NCBI

40 

Ueki Y and Reh TA: Activation of BMP-Smad1/5/8 signaling promotes survival of retinal ganglion cells after damage in vivo. PLoS One. 7:e386902012. View Article : Google Scholar : PubMed/NCBI

41 

Poittevin M, Bonnin P, Pimpie C, Rivière L, Sebrié C, Dohan A, Pocard M, Charriaut-Marlangue C and Kubis N: Diabetic microangiopathy: Impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice. Diabetes. 64:999–1010. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Meng H, Song Y, Zhu J, Liu Q, Lu P, Ye N, Zhang Z, Pang Y, Qi J, Wu H, Wu H, et al: LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain. Mol Med Rep 14: 5535-5543, 2016.
APA
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N. ... Wu, H. (2016). LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain. Molecular Medicine Reports, 14, 5535-5543. https://doi.org/10.3892/mmr.2016.5925
MLA
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N., Zhang, Z., Pang, Y., Qi, J., Wu, H."LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain". Molecular Medicine Reports 14.6 (2016): 5535-5543.
Chicago
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N., Zhang, Z., Pang, Y., Qi, J., Wu, H."LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain". Molecular Medicine Reports 14, no. 6 (2016): 5535-5543. https://doi.org/10.3892/mmr.2016.5925
Copy and paste a formatted citation
x
Spandidos Publications style
Meng H, Song Y, Zhu J, Liu Q, Lu P, Ye N, Zhang Z, Pang Y, Qi J, Wu H, Wu H, et al: LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain. Mol Med Rep 14: 5535-5543, 2016.
APA
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N. ... Wu, H. (2016). LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain. Molecular Medicine Reports, 14, 5535-5543. https://doi.org/10.3892/mmr.2016.5925
MLA
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N., Zhang, Z., Pang, Y., Qi, J., Wu, H."LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain". Molecular Medicine Reports 14.6 (2016): 5535-5543.
Chicago
Meng, H., Song, Y., Zhu, J., Liu, Q., Lu, P., Ye, N., Zhang, Z., Pang, Y., Qi, J., Wu, H."LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain". Molecular Medicine Reports 14, no. 6 (2016): 5535-5543. https://doi.org/10.3892/mmr.2016.5925
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team